Ajanta Pharma fixes book closure for dividend AGM

Ajanta Pharma has informed that Mr. Rajesh M. Agrawal and Mr. K H Viswanathan have been appointed as Additional Directors w.e.f. April 30, 2013.

Gabs Investments, one of the promoters of Ajanta Pharma has acquired 18,169 shares worth Rs 1.43 crore of the company through open market transaction in past three trading sessions. Since April, Gab Investments had purchased 52,043 shares of the ...

In a chat with ET Now, Prakash Gaba, CFT, prakashgaba.com shares his view on Ajanta Pharma ET Now: What is your view Ajanta Pharma? Prakash Gaba: Ajanta Pharma is a buy call. We can see levels closer to 950, stop

Ajanta Pharma Ltd has announced the Financial Results for the period ended March 31, 2013.The company has reported Net Sales / Income from Operations of Rs.249.44 crores for the quarter ended March 31, 2013 against Rs.176.10 crores for the quarter ...

In CNBC-TV18's popular show Bull's Eye, SP Tulsian, sptulsian.com shares his trading strategies for the day.

Ajanta Pharma at its meeting held on April 30, 2013, has recommended dividend at Rs 6.25 per equity share of the face value of Rs 5 each, subject to approval of Shareholders at the ensuing Annual General Meeting to be held on July 13, 2013.

Ajanta Pharma has touched a 52-week high of Rs 804. At 14:12 hrs the share was quoting at Rs 776.55, up Rs 43.65, or 5.96 percent.

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

Ajanta Pharma (APL) has yet again posted better than expected results with Q4FY13 sales growth of 42% yoy. EBITDA margins rose by 481 bps yoy to 27.4% on account of higher economies of scale. Key Highlights - Sales grew by 41.6% YoY on account of ...